| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| dexloxiglumide | cholecystokinin receptor type a | small molecule | Clinical trial target | TTD , drugbank , DGIDB | Irritable Bowel Syndrome[MeSHID:D043183] Gastroesophageal reflux disease[MeSHID:D005764] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Pancreas[MeSHID:D010179] |
23.87 | investigational,phase 2 | unknown |
| dexloxiglumide | cholecystokinin receptor type a | small molecule | Clinical trial target | TTD , drugbank , DGIDB | Irritable Bowel Syndrome[MeSHID:D043183] Gastroesophageal reflux disease[MeSHID:D005764] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Pancreas[MeSHID:D010179] |
23.87 | investigational,phase 2 | antagonist |
| dexloxiglumide | gastrin/cholecystokinin type b receptor | NA | Successful target | TTD | Irritable Bowel Syndrome[MeSHID:D043183] Gastroesophageal reflux disease[MeSHID:D005764] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Pancreas[MeSHID:D010179] |
NA | phase 2 | unknown |
| click here to return to the previous page | ||||||||